Northwestern Mutual Wealth Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$785	Buy	503 +3	+0.6%	+$4	﹤0.01%	3792
2025 Q4	$575	Sell	500 -14	-3%	-$19	﹤0.01%	3702
2025 Q3	$694	Buy	514 +14	+3%	+$16	﹤0.01%	3600
2025 Q2	$473	Hold	500	–	–	﹤0.01%	3454
2025 Q1	$230	Hold	500	–	–	﹤0.01%	3443
2024 Q4	$369	Hold	500	–	–	﹤0.01%	3410
2024 Q3	$785	Hold	500	–	–	﹤0.01%	3285
2024 Q2	$840	Hold	500	–	–	﹤0.01%	3232
2024 Q1	$1.2K	Hold	500	–	–	﹤0.01%	3146
2023 Q4	$765	Hold	500	–	–	﹤0.01%	3222
2023 Q3	$545	Hold	500	–	–	﹤0.01%	3112
2023 Q2	$1.15K	Hold	500	–	–	﹤0.01%	3069
2023 Q1	$1.22K	Hold	500	–	–	﹤0.01%	2996
2022 Q4	$955	Hold	500	–	–	﹤0.01%	3049
2022 Q3	$1K	Hold	500	–	–	﹤0.01%	2991
2022 Q2	$1K	Hold	500	–	–	﹤0.01%	3041
2022 Q1	$1K	Hold	500	–	–	﹤0.01%	3001
2021 Q4	$2K	Hold	500	–	–	﹤0.01%	2955
2021 Q3	$2K	Hold	500	–	–	﹤0.01%	2858
2021 Q2	$2K	Hold	500	–	–	﹤0.01%	2815
2021 Q1	$3K	Hold	500	–	–	﹤0.01%	2534
2020 Q4	$2K	Hold	500	–	–	﹤0.01%	2538
2020 Q3	$1K	Hold	500	–	–	﹤0.01%	2455
2020 Q2	$1K	Hold	500	–	–	﹤0.01%	2300
2020 Q1	$1K	Hold	500	–	–	﹤0.01%	2417
2019 Q4	$2K	Hold	500	–	–	﹤0.01%	2230
2019 Q3	$2K	Sell	500 -613	-55%	-$1.9K	﹤0.01%	2275
2019 Q2	$7K	Hold	1,113	–	–	﹤0.01%	2046
2019 Q1	$6K	Hold	1,113	–	–	﹤0.01%	2101
2018 Q4	$7K	Sell	1,113 -66	-6%	-$535	﹤0.01%	1950
2018 Q3	$13K	Sell	1,179 -39,158	-97%	-$449K	﹤0.01%	1839
2018 Q2	$484K	Sell	40,337 -2,306	-5%	-$23.6K	﹤0.01%	541
2018 Q1	$365K	Buy	42,643 +543	+1%	+$5.02K	﹤0.01%	581
2017 Q4	$416K	Sell	42,100 -285	-0.7%	-$2.96K	﹤0.01%	548
2017 Q3	$521K	Sell	42,385 -500	-1%	-$7.38K	﹤0.01%	470
2017 Q2	$705K	Buy	42,885 +1,615	+4%	+$25K	0.01%	414
2017 Q1	$592K	Buy	41,270 +1,982	+5%	+$29.4K	0.01%	422
2016 Q4	$543K	Buy	+39,288	New	+$630K	0.01%	431
2016 Q3	–	Sell	-42,705	Closed	-$613K	–	955
2016 Q2	$613K	Sell	42,705 -714	-2%	-$9.68K	0.01%	369
2016 Q1	$519K	Buy	43,419 +2,386	+6%	+$25K	0.01%	384
2015 Q4	$546K	Sell	41,033 -4,864	-11%	-$59.8K	0.01%	339
2015 Q3	$493K	Buy	45,897 +24,300	+113%	+$265K	0.01%	334
2015 Q2	$174K	Buy	21,597 +14,048	+186%	+$103K	﹤0.01%	470
2015 Q1	$50K	Buy	7,549 +7,000	+1,275%	+$47.8K	﹤0.01%	650
2014 Q4	$3K	Hold	549	–	–	﹤0.01%	1417
2014 Q3	$5K	Hold	549	–	–	﹤0.01%	1030
2014 Q2	$6K	Buy	549 +506	+1,177%	+$5.43K	﹤0.01%	987
2014 Q1	$1K	Hold	43	–	–	﹤0.01%	1210
2013 Q4	$1K	Hold	43	–	–	﹤0.01%	1308
2013 Q3	$1K	Hold	43	–	–	﹤0.01%	1280
2013 Q2	$1K	Buy	+43	New	+$653	﹤0.01%	1187

Other funds holding LXRX

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Northwestern Mutual Wealth Management's LXRX Position: Q1 2026 in Review

Northwestern Mutual Wealth Management increased its Lexicon Pharmaceuticals (LXRX) stake by 0.6% in Q1 2026, buying an estimated $4 and bringing the position to 503 shares worth $785. The position accounts for ﹤0.01% of the portfolio, ranked #3792.

Northwestern Mutual Wealth Management first reported a position in LXRX in Q2 2013 and has held it in 51 quarters since. The position peaked at $705K in Q2 2017. 136 funds tracked by Wall St. Rank hold LXRX as of Q1 2026.

Northwestern Mutual Wealth Management held 503 shares of Lexicon Pharmaceuticals worth $785 as of Q1 2026.
Northwestern Mutual Wealth Management bought 3 Lexicon Pharmaceuticals shares in Q1 2026, an estimated $4.
Lexicon Pharmaceuticals made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3792 holding.
Northwestern Mutual Wealth Management first reported a position in Lexicon Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
Northwestern Mutual Wealth Management's Lexicon Pharmaceuticals position peaked at $705K in Q2 2017.
136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.